Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // July 9th, 2010 // 6:20 am
And so another work week will soon draw to a close. And not a moment too soon, yes? After the heat of the past few days, a cooling off is a good thing. Our plans are rather modest - a dip in the pool and a bit of exercise which, as always, includes promenading with the official Pharmalot mascots. Of course, some Avandia reading is de rigeur these days, too. Whatever is on your agenda, we hope your weekend is pleasant. Meanwhile, here are some headlines to help you along. Take care…
UK’s NICE Rejects Roche’s Avastin For Metastatic Breast Cancer (Bloomberg News)
J&J Recalls More Tylenol And OTC Products (Reuters)
Alcon Directors Create Legal Fund For Novartis Battle (PharmaTimes)
European Regulator Starts Avandia Safety Review (EMA statement)
An AIDS Vaccine Appears One Step Closer (Bloomberg News)
FDA Warns Against Quinine For Leg Cramps (Los Angeles Times)
Merck KGgA Chief To Head Millipore (Boston Herald)
Avid Leads The Race For Alzheimer’s Imaging Test (Bloomberg News)
Infinity Licenses PI3K Program From Intellikine in $489M Deal (BioWorld Today)
photo courtesy of titlap on flickr creative commons
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
AIDS, Alcon, Alzheimers, Avandia, Avastin, Avid Radiopharmaceutials, Breast Cancer, European Medicines Agency, GlaxoSmithKline, HIV, Infinity Pharmaceuticals, Intellikine, Johnson & Johnson, Leg Cramps, Merck KgGA, Millicore, NICE, Novartis, PI3K, Quinine, Roche, Tylenol, Vaccines